Hans Van Bruggen

Chief Scientific Officer at Celegence

Hans van Bruggen has extensive experience in regulatory operations and consultancy, primarily focused on XEVMPD and IDMP data implementation. Hans has worked with various companies in the pharmaceutical industry and has been actively involved in presenting and co-organizing events related to regulatory affairs. Hans is also a board member of IRISS Forum, contributing to the improvement of regulatory information exchange. Their educational background includes a Master's degree in Pharmaceutical Medicine from the University of Surrey.

Links

Previous companies

Santen logo

Timeline

  • Chief Scientific Officer

    July, 2022 - present